
    
      The present study attempts to evaluate the efficacy of adiponectin, ADA, and foot bone
      mineral density (fBMD) as predictors of the disease progression in patients with rheumatoid
      arthritis. A total of 80 RA patients and eighty age and sex-matched healthy controls were
      included in this study.
    
  